Drugs / Poliomyelitis Vaccine bivalent types 1 and 3
Poliomyelitis Vaccine bivalent types 1 and 3
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04429295 Comparator | Jun 2020 → Feb 2021 | Rotavirus infection, diphtheria, haemophilus meningitis, hepatitis B virus infection +3 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Poliomyelitis Vaccine bivalent types 1 and 3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04429295 ↗ |
| Modality | Vaccine | “bivalent oral poliovirus (bOPV) vaccines” PMID 37257121 ↗ Apr 2023 |
| Route | Oral | “Route of administration: Oral” NCT04429295 ↗ |